Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment

Publisher： Karger

E-ISSN： 1662-6575|6|3|531-537

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.6, Iss.3, 2013-10, pp. : 531-537

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virological and Biochemical Relapse after Discontinuation of Lamivudine Monotherapy for Chronic Hepatitis B in Japan: Comparison with Breakthrough Hepatitis during Long-Term Treatment

By  

Intervirology, Vol. 48, Iss. 2-3, 2005-03 ,pp. : 174-182

Karger

Access to resources Recommend Favorite

A Near-Complete Response to Treatment with Gemcitabine plus nab®-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-10 ,pp. : 711-717

Karger

Access to resources Recommend Favorite

Testicular Relapse after 13 Years of Complete Remission of Acute Lymphoblastic Leukemia

By  

Urologia Internationalis, Vol. 60, Iss. 4, 1998-08 ,pp. : 239-241

Karger

Access to resources Recommend Favorite

Sorafenib Monotherapy in a Patient with Unresectable Hepatic Epithelioid Hemangioendothelioma

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-02 ,pp. : 134-137

Karger

Access to resources Recommend Favorite

Ten Years of Complete Remission of Pulmonary Metastasis after Post-Cystectomy Palliative Cisplatin-Gemcitabine Chemotherapy with Gefitinib for Muscle Invasive Bladder Cancer: A Case Report

By  

Urologia Internationalis, Vol. 97, Iss. 4, 2016-02 ,pp. : 485-488

Karger

Access to resources Recommend Favorite